Trial Information
Inclusion Criteria:
- Polycythemia vera
- Treatment by therapeutic bleedings
- No cytotoxic treatment during the previous six months
Exclusion Criteria:
- No Polycythemia vera
- No treatment by therapeutic bleedings
- Cytotoxic treatment during the previous six months
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
To describe immunologic anomalies in polycythemia vera
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
Regis Costello
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistance Publique Hopitaux De Marseille
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
2009/16
NCT ID:
NCT01284712
Start Date:
July 2009
Completion Date:
Related Keywords:
- Polycythemia Vera
- treatment by bleedings
- Polycythemia
- Polycythemia Vera